Opinions expressed by Digital Journal contributors are their own. Bringing a new biologic drug from concept to clinic is a complex journey fraught with technical and regulatory hurdles. For ...
OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics, a U.S.-based Contract Development and Manufacturing Organization (CDMO), announced the launch of its in-house formulation development services, ...
HCW Biologics Inc. and WY Biotech Co., Ltd. have finalized a licensing agreement for the development and commercialization of HCW11-006, a novel immunotherapy targeting age-related diseases and cancer ...
Documentary standards such as monographs, general chapters, and reference standards are essential for efficiently meeting regulatory requirements and ensuring the intended efficacy and safety of drugs ...
While agents like AbbVie's Humira have transformed the treatment landscape, not all patients benefit equally from the drug.
Intravacc offers state-of-the-art analytical methods for identity, content, purity, structure, formulation, stability, and preclinical assessment Capabilities include ...
White paper outlines how BioDlink’s predictive digital platform reduces freeze-drying cycle development from over 60 days to under 30, enhancing scale-up precision for complex biologics A case study ...
Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed ...
This Brush Up is sponsored by MilliporeSigma. Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug ...
The U.S. Food and Drug Administration (FDA) announced on Wednesday (October 29) a plan to streamline the approval process for biosimilars, which are generic versions of complex biological drugs. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results